Arthritis remains a significant health burden in India, particularly among the aging population. Managing chronic pain and inflammation requires effective drug delivery methods that ensure high bioavailability. Traditional oral medications often lead to gastrointestinal side effects, while injections can be painful and carry infection risks. Consequently, scientists have developed innovative electroporation patches for arthritis to provide a breathable and stretchable solution for transdermal delivery.

The Breathable, Stretchable Electroporation Patch (BSEP) integrates screen-printed conductive ink on a non-woven fabric substrate. This specific design allows the patch to adhere comfortably to the skin even during joint movement. Furthermore, the unique serpentine interdigitated electrodes precisely localize electric fields within superficial skin layers. This precision reduces voltage exposure in deep tissues by 50%, which significantly minimizes potential damage or pain. Similarly, researchers confirmed the safety of these materials through extensive cytotoxicity and histological testing.

Advancing Care with Electroporation Patches for Arthritis

Notably, animal trials demonstrate that the BSEP achieves a two-to-threefold increase in skin penetration compared to traditional control patches. This enhancement ensures that therapeutic agents reach the target site more efficiently. Moreover, the low-cost manufacturing process makes this technology highly accessible for large-scale clinical use. Therefore, these findings suggest that combining comfort with high performance can transform long-term management for millions of patients. In addition, this advancement offers a promising alternative to current invasive therapies.

Frequently Asked Questions

What makes these patches breathable and stretchable?

The patches utilize a non-woven fabric substrate with screen-printed serpentine electrodes. This construction allows the device to flex and breathe while maintaining consistent electrical contact with the skin during daily activities.

Are there any risks of tissue damage from the electric field?

The design specifically localizes the electric field to superficial skin layers. By reducing the voltage in deeper tissues by half, the technology significantly minimizes the risk of pain or tissue damage compared to traditional electroporation methods.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Li Z et al. Breathable, Stretchable Electroporation Patches for Drug Delivery. Small. 2026 May 03. doi: 10.1002/smll.73624. PMID: 42070295.

Singh N, Choudhary R. Recent Advancement in Drug Delivery Systems for the Treatment of Rheumatoid Arthritis. Curr Drug Discov Technol. 2025 Jul 11. doi: 10.2174/0115701638376838250701221200.

Dermol-Černe J, et al. Mechanistic view of skin electroporation – models and dosimetry for successful applications: An expert review. Expert Opin Drug Deliv. 2020;17(5):689-704. doi: 10.1080/17425247.2020.1745771.